K2 Principal Fund’s Atea Pharmaceuticals AVIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-605,419	Closed	-$3.45M	–	185
2022 Q3	$3.45M	Sell	605,419 -1,000,640	-62%	-$5.69M	0.4%	34
2022 Q2	$11.4M	Buy	+1,606,059	New	+$11.4M	1.26%	8